An. Chakrabarty et al., ANTIMYCOBACTERIAL ACTIVITY OF METHDILAZINE (MD), AN ANTIMICROBIC PHENOTHIAZINE, APMIS. Acta pathologica, microbiologica et immunologica Scandinavica, 101(6), 1993, pp. 449-454
Methdilazine (Md) could inhibit various Mycobacterium spp. at 5-15 mug
/ml concentrations in vitro as well as in vivo. When Md was tested in
combination with streptomycin (Sm), rifampicin (Rf) or methyl-DOPA (m-
D), it showed synergistic effects only with respect to methyl-DOPA.